Role of Instructions in Nitrous Oxide Effects and Choice - 10
NCT00000258 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22
Last updated 2015-05-28
Summary
The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To evaluate the role of instructions in nitrous oxide subjective effects and choice.
Conditions
- Opioid-Related Disorders
- Substance-Related Disorders
Interventions
- DRUG
-
Nitrous oxide 10% & placebo
- DRUG
-
Nitrous oxide 20% & placebo
- DRUG
-
Nitrous oxide 30% & placebo
- DRUG
-
Nitrous oxide 40% and placebo
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of Chicago
lead OTHER
Principal Investigators
-
James Zacny, Ph.D. · University of Chicago
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 21 Years
- Max Age
- 32 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-04-30
- Primary Completion
- 1997-11-30
- Completion
- 1997-11-30
Countries
- United States
Study Locations
More Related Trials
-
Network-Level Effects of Nitrous Oxide in the Human Brain
NCT03435055 ·Status: COMPLETED ·Phase: PHASE4
-
Individual Differences in the Response to Drugs
NCT02485158 ·Status: COMPLETED ·Phase: NA
-
Nitrous Oxide and EMOtional Cognition
NCT06557642 ·Status: RECRUITING ·Phase: NA
-
Behavioral Pharmacology of THC and D-limonene
NCT03609853 ·Status: COMPLETED ·Phase: PHASE1
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Effect of Nitrous Oxide on Aggression.
NCT06118567 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Behavior Brain Responses
NCT03964350 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of Ketamine on Laboratory-induced Stress in Healthy Subjects
NCT04173962 ·Status: COMPLETED ·Phase: PHASE2
-
Nitrous Oxide- Suicidal Ideation
NCT03736538 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Effects of Commonly Used Medications on Mood and Choice
NCT03652740 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
NCT03679949 ·Status: COMPLETED ·Phase: PHASE1
-
Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim
NCT04970342 ·Status: COMPLETED ·Phase: PHASE1
-
Developing a Mobile Method to Measure THC-induced Impairment
NCT03804840 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
NCT05287256 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome
NCT03066193 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
NCT03060031 ·Status: COMPLETED ·Phase: PHASE1
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4
-
Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]
NCT04178993 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
NCT07214155 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
The Influence of Intranasal Oxytocin on Communication
NCT02415920 ·Status: COMPLETED ·Phase: NA
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02710097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Acquisition of Responses to a Methamphetamine-associated Cue in Healthy Humans
NCT02323048 ·Status: COMPLETED ·Phase: NA
-
Behavioral Pharmacology of Orally Administered THC and D-limonene
NCT06378957 ·Status: RECRUITING ·Phase: PHASE1